Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Announcement on Progress in Retrial of Significant Litigation Matters

· Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange
Announcement on Progress in Retrial of Significant Litigation Matters

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment